Author:
Tamhaev Rasoul,Grosjean Emeline,Ahamed Hikmat,Chebaiki Mélina,Rodriguez Frédéric,Recchia Deborah,Degiacomi Giulia,Pasca Maria Rosalia,Maveyraud Laurent,Mourey Lionel,Lherbet Christian
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Reference36 articles.
1. WHO, Global Tuberculosis Report 2022, World Health Organization, Geneva, 2022.
2. New agents for the treatment of drug-resistant Mycobacterium tuberculosis;Hoagland;Adv. Drug Deliv. Rev.,2016
3. Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis;Vilcheze;J. Bacteriol.,2000
4. The Mycobacterium tuberculosis FAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development;Bhatt;Mol. Microbiol.,2007
5. Crystal structure of the enoyl-ACP reductase of Mycobacterium tuberculosis (InhA) in the apo-form and in complex with the active metabolite of isoniazid pre-formed by a biomimetic approach;Chollet;J. Struct. Biol.,2015
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献